Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version

• Luis Pino,
• Carlos Perez,
• Andres Cardona,
• Ivan Triana

Affiliations

Luis Pino

Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia

Carlos Perez

Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia

Andres Cardona

Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia

Ivan Triana

Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia